When a manufacturer announces a medical device radiation protection study with large percentage reductions, hospital buyers and safety officers have to decide how much weight to give it. Egg Medical issued such an announcement on 21 October 2026 about its EggNest Complete shielding system, citing a study in the Journal of the American Heart Association (JAHA) at The Christ Hospital in Cincinnati. This article sets out the reported results and the questions a careful reader should ask before relying on them.
Key takeaways from the medical device radiation protection study
- According to Egg Medical, estimated annual collar dose for the primary operator fell from 86.7 mRem to 25.5 mRem with EggNest Complete (p < 0.001).
- In a second comparison, annualised EDE-1 was 51.4 mRem with 0.5 mm lead aprons and standard shielding versus 1.4 mRem with 0.125 mm ultralight aprons plus EggNest Complete.
- The release does not state sample size, procedure counts, instruments, study period or limitations.
- We did not locate the JAHA paper, and the release gives no DOI, so every figure here is the company’s description.
- One study at one site does not establish the same result at other hospitals, and this medical device radiation protection study should be read in that light.
The medical device radiation protection study in brief
The company describes a prospective, real-world clinical study with Dr. Santiago Garcia of The Christ Hospital as principal investigator. It compared standard shielding with operators in heavy 0.5 mm lead aprons against EggNest Enhanced Radiation Protection Devices paired with 0.125 mm ultralight aprons. It says total effective doses for primary operators, scrub assistants and circulating nurses were about 1% of the 5,000 mRem annual maximum it attributes to the ICRP.
By our own arithmetic, the collar-dose result is 61.2 mRem lower, about 71%, and the EDE-1 result is 50 mRem lower, about 97%. Those percentages are our calculations from the company’s numbers. The company’s website and the full release are the primary sources.
General background: how to read a company-sourced result
A manufacturer’s release is a legitimate source for what the company claims, but it is not the same as an independent evaluation. Readers assessing a device study usually look at five things: how many cases were measured, how exposure was recorded, what the comparison group was, whether the endpoints were set in advance, and whether the authors have financial ties to the maker. This is general method and not a criticism of this particular study.
Applied to the EggNest release, the answers are mostly missing. The number of cases is not given. The dosimeters are not described. The comparison bundles two changes at once, apron weight and shielding. The release says the study was prospective, which suggests a planned design, but we cannot confirm what was pre-specified. Author relationships are not stated, though one clinician quoted in the release is described by the company as a past president of a professional society.
What a medical device radiation protection study of this kind can show
A dosimetry study of this kind can show whether measured staff exposure falls under particular conditions at the sites studied. It can support hospital radiation safety committees that are deciding whether to trial a device. It cannot show health outcomes, and the release makes no claim about them. It also cannot show that the same reduction will occur in a different lab, with different operators, procedures and room layouts.
The ICRP provides the dose-limit framework referenced in the release. One detail is worth noting: 5,000 mRem equals 50 mSv, while ICRP guidance also uses an average of 20 mSv a year over five years. The benchmark chosen changes how large the reported doses look. That is general background and not a statement from the company.
Our analysis: what would strengthen the evidence
In our assessment, the medical device radiation protection study is a reasonable starting point for local trials but not a basis for changing practice by itself. What would strengthen it is a published paper with case counts and dosimetry methods, results from other sites and procedure types, and a comparison that separates the device from the apron change. The company says evaluation in other procedure types is ongoing, and those results would be informative.
Buyers weighing lead apron alternatives can ask the vendor for the paper, the raw dose tables and any independent data. For related coverage see our medical devices section. This is analysis and not advice.
What is not disclosed about the medical device radiation protection study
- Number of procedures, operators and staff measured.
- Measurement method, dosimeter placement and period.
- Authors, title, DOI and stated limitations.
- Funding and financial relationships with Egg Medical.
- Terms and date of the Texas variance the company cites.
Risks and caveats for the medical device radiation protection study
The release also mentions that the Texas Department of State Health Services recently granted a state radiation variance to Methodist Healthcare System of San Antonio. No date or terms are given, and we have not seen it. A variance in one state is not a national standard. Nothing here is medical, regulatory or purchasing advice; radiation safety decisions should involve a hospital’s own radiation safety officer and applicable rules.
What to watch next
- The published paper and its data tables, including the study’s own limitations, listed under the journal at ahajournals.org.
- Independent studies of radiation shielding in catheterisation labs at other centres.
- Professional society statements on apron-optional work and interventional cardiology workplace safety.
FAQ
What is the medical device radiation protection study about?
It is a study at The Christ Hospital of staff radiation dose with and without the EggNest Complete shielding system, as described by Egg Medical.
Can the medical device radiation protection study apply to any hospital?
Not on this evidence. The release describes one site and gives no sample size, so it cannot show the same outcome elsewhere.
Is the study independent?
The release comes from the device maker, and it does not state funding or author financial relationships. We cannot say whether the study was independent.
How we reported this: we read the company release and attributed every figure to Egg Medical. Calculations are labelled as ours. Last updated 23 October 2026. This is news reporting and not advice.
